Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Caribou Property Limited investment portfolio
Caribou Property Limited has made numerous investments in companies such as Macomics, Epsilogen, and Lunac Therapeutics within the Biotech sector.
unknown
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Epsilogen Ltd Epsilogen develops immunoglobulin E (IgE) antibody therapeutics for the treatment of cancer, targeting oncology patients. | Healthcare & Life Sciences | London | Confirmed | 2025-07-25 |
| Lunac Therapeutics Limited LUNAC Therapeutics develops next‑generation oral anticoagulant therapies that target activated Factor XIIa, aiming to provide safer blood‑clotting treatment options for patients requiring anticoagulation. | Healthcare & Life Sciences | London | Confirmed | 2025-04-17 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (3)
Caribou Property Limited's positions across portfolio companies2026
- SERIES B 4,525,427 → 6,633,697
2025
- SERIES B 3,922,364 → 4,525,427
- ORDINARY 0 → 603,063
Articles (1)
- 9 Jun 2026